BG100747A - INDOLE DERIVATIVES AS 5-HT1 agonists - Google Patents

INDOLE DERIVATIVES AS 5-HT1 agonists

Info

Publication number
BG100747A
BG100747A BG100747A BG10074796A BG100747A BG 100747 A BG100747 A BG 100747A BG 100747 A BG100747 A BG 100747A BG 10074796 A BG10074796 A BG 10074796A BG 100747 A BG100747 A BG 100747A
Authority
BG
Bulgaria
Prior art keywords
group
agonists
indole derivatives
optionally substituted
cycloalkyl
Prior art date
Application number
BG100747A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Glen
Christopher Foster
David Selwood
Graeme Martin
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of BG100747A publication Critical patent/BG100747A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG100747A 1994-01-26 1996-07-25 INDOLE DERIVATIVES AS 5-HT1 agonists BG100747A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401436A GB9401436D0 (en) 1994-01-26 1994-01-26 Therapeutic heterocyclic compounds
PCT/GB1995/000142 WO1995020588A1 (en) 1994-01-26 1995-01-25 Indole derivatives as 5-ht1 agonists

Publications (1)

Publication Number Publication Date
BG100747A true BG100747A (en) 1997-03-31

Family

ID=10749321

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100747A BG100747A (en) 1994-01-26 1996-07-25 INDOLE DERIVATIVES AS 5-HT1 agonists

Country Status (26)

Country Link
US (3) US5744466A (sk)
EP (1) EP0741725A1 (sk)
JP (1) JPH09512248A (sk)
CN (1) CN1143960A (sk)
AP (1) AP632A (sk)
AU (2) AU689195B2 (sk)
BG (1) BG100747A (sk)
BR (1) BR9506581A (sk)
CA (1) CA2181475A1 (sk)
CZ (1) CZ216996A3 (sk)
EE (1) EE9600095A (sk)
FI (1) FI962969A (sk)
GB (1) GB9401436D0 (sk)
HU (1) HUT76288A (sk)
IL (1) IL112443A (sk)
MX (1) MX9602979A (sk)
NO (1) NO963117L (sk)
NZ (1) NZ278644A (sk)
OA (1) OA10307A (sk)
PL (1) PL315666A1 (sk)
SG (1) SG44926A1 (sk)
SK (1) SK96796A3 (sk)
TW (1) TW377344B (sk)
WO (1) WO1995020588A1 (sk)
YU (1) YU4795A (sk)
ZA (1) ZA95601B (sk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376463B1 (en) * 1992-04-07 2002-04-23 Emory University Modified factor VIII
GB9515060D0 (en) * 1995-07-22 1995-09-20 Wellcome Found Therapeutic heterocyclic compounds
GB9515305D0 (en) * 1995-07-26 1995-09-20 Wellcome Found Therapeutic heterocyclic compounds
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
GB9516143D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
US6909005B1 (en) 1995-08-07 2005-06-21 Astrazeneca Uk Limited One post synthesis of 2-oxazolidinone derivatives
AU2104097A (en) * 1996-03-13 1997-10-01 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
US5654431A (en) * 1996-05-30 1997-08-05 Meng; Qingchang 5-alkoxy tryptamine derivatives
AU5194999A (en) * 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
BR0015401A (pt) * 1999-11-08 2002-07-02 Wyeth Corp [(indol-3-il)-cicloalquil]-3-azetidinas substituìdas para o tratamento de distúrbios do sistema nervoso central
US6245799B1 (en) 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
CA2403806A1 (en) * 2000-03-23 2002-09-20 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
US6462234B2 (en) * 2000-09-18 2002-10-08 Pharmacia & Upjohn Company Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide
CA2433100A1 (en) 2000-12-27 2002-07-04 Helmut Haning Indole derivatives as ligands of thyroid receptors
CA2610655A1 (en) 2005-06-03 2006-12-14 Abbott Laboratories Cyclobutyl amine derivatives
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
CN103382174A (zh) 2006-06-23 2013-11-06 雅培制药有限公司 作为组胺h3受体调节物的环丙胺衍生物
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2014164467A1 (en) 2013-03-13 2014-10-09 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
US11787814B2 (en) * 2019-07-11 2023-10-17 Ascentage Pharma (Suzhou) Co., Ltd. Method for preparing 2-indolinospirone compound and intermediate thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
IL92096A0 (en) * 1988-10-25 1990-07-12 Abbott Lab Carboxylic nucleoside analogs
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
IL114690A (en) * 1990-06-07 1997-02-18 Wellcome Found Antimigraine oxazolidinone substituted indole derivatives
CA2138649A1 (en) * 1992-07-24 1994-02-03 Raymond Baker Imidazole, triazole and tetrazole derivatives

Also Published As

Publication number Publication date
US6103752A (en) 2000-08-15
NO963117D0 (no) 1996-07-25
TW377344B (en) 1999-12-21
YU4795A (sh) 1998-12-23
HUT76288A (en) 1997-07-28
AP632A (en) 1998-03-30
FI962969A0 (fi) 1996-07-25
OA10307A (en) 1997-10-07
CA2181475A1 (en) 1995-08-03
HU9602035D0 (en) 1996-09-30
FI962969A (fi) 1996-07-25
US5744466A (en) 1998-04-28
SK96796A3 (en) 1997-06-04
WO1995020588A1 (en) 1995-08-03
AU1462095A (en) 1995-08-15
AU689195B2 (en) 1998-03-26
IL112443A (en) 1998-12-27
US5922748A (en) 1999-07-13
IL112443A0 (en) 1995-03-30
AU6348998A (en) 1998-06-18
AP9600834A0 (en) 1996-07-31
NO963117L (no) 1996-09-23
ZA95601B (en) 1996-07-25
NZ278644A (en) 1998-02-26
CN1143960A (zh) 1997-02-26
CZ216996A3 (en) 1997-06-11
EP0741725A1 (en) 1996-11-13
GB9401436D0 (en) 1994-03-23
BR9506581A (pt) 1997-09-23
SG44926A1 (en) 1997-12-19
PL315666A1 (en) 1996-11-25
JPH09512248A (ja) 1997-12-09
EE9600095A (et) 1996-12-16
MX9602979A (es) 1998-01-31

Similar Documents

Publication Publication Date Title
BG100747A (en) INDOLE DERIVATIVES AS 5-HT1 agonists
DE69620443D1 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
IL127296A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
AP2001002114A0 (en) Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents).
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
YU13502A (sh) Derivati amino-triazolopiridina
MX9705590A (es) Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen.
ATE217623T1 (de) Azindolethylaminderivate als nikotin-acetylcholin-rezeptor bindung verbindungen
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
TW341565B (en) Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them
ATE233239T1 (de) Enantiomere von carbazolderivaten als 5-ht1- ähnliche agonisten
SE8505715L (sv) Indolderivat
TR199902897T2 (xx) S�v� benz-izo-kuinolin t�revleri.
MY113266A (en) New indol derivatives derivatives with high affinity 5-ht1a receptor.
ATE224371T1 (de) N-substituierte beta-aryl und beta-heteroaryl- alpha-cyamoacrylamidderivate als tyrosine kinase inhibitoren
EP0275482A3 (en) Novel prolinal derivatives
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
NO173869C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,7-kondenserte 1h-indol-2-carboxylsre-n-(1,4-benzodiazepin-3-yl)-amider
AU4632996A (en) Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
DE59304311D1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
ATE237611T1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
CA2093510A1 (en) Oxysulfonyl carbamates
DE69633289D1 (de) 4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten
AU6531296A (en) Benzocycloalkene compounds with melatonine receptor binding affinity, their production and use
AU4583489A (en) New indole derivatives, process for preparing them and pharmaceutical compositions containing them